TMCI Stock Overview
A medical technology company, designs, manufactures, and markets medical devices in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Treace Medical Concepts, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.88 |
| 52 Week High | US$26.63 |
| 52 Week Low | US$3.92 |
| Beta | 0.37 |
| 1 Month Change | -45.10% |
| 3 Month Change | -56.18% |
| 1 Year Change | -78.04% |
| 3 Year Change | -83.68% |
| 5 Year Change | n/a |
| Change since IPO | -76.97% |
Recent News & Updates
Recent updates
Market Still Lacking Some Conviction On Treace Medical Concepts, Inc. (NASDAQ:TMCI)
Apr 05
Does Treace Medical Concepts (NASDAQ:TMCI) Have A Healthy Balance Sheet?
Feb 09Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) 31% Share Price Surge
Jan 04Market Cool On Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Revenues Pushing Shares 46% Lower
Nov 11Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its Second-Quarter Results
Aug 13Shareholder Returns
| TMCI | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 14.0% | -1.2% | -1.2% |
| 1Y | -78.0% | 1.8% | 21.5% |
Return vs Industry: TMCI underperformed the US Medical Equipment industry which returned 1.8% over the past year.
Return vs Market: TMCI underperformed the US Market which returned 21.5% over the past year.
Price Volatility
| TMCI volatility | |
|---|---|
| TMCI Average Weekly Movement | 20.3% |
| Medical Equipment Industry Average Movement | 7.8% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: TMCI's share price has been volatile over the past 3 months.
Volatility Over Time: TMCI's weekly volatility has increased from 14% to 20% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 516 | John Treace | www.treace.com |
Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision.
Treace Medical Concepts, Inc. Fundamentals Summary
| TMCI fundamental statistics | |
|---|---|
| Market cap | US$364.18m |
| Earnings (TTM) | -US$54.75m |
| Revenue (TTM) | US$196.03m |
1.9x
P/S Ratio-6.7x
P/E RatioIs TMCI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TMCI income statement (TTM) | |
|---|---|
| Revenue | US$196.03m |
| Cost of Revenue | US$37.27m |
| Gross Profit | US$158.76m |
| Other Expenses | US$213.51m |
| Earnings | -US$54.75m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.88 |
| Gross Margin | 80.99% |
| Net Profit Margin | -27.93% |
| Debt/Equity Ratio | 42.0% |
How did TMCI perform over the long term?
See historical performance and comparison